Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-10-02

Clinical Trial Update: Does Melatonin Restore Sleep Architecture in Autistic Children [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating melatonin for improving sleep architecture in autistic children has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Melatonin (melatonin)

Snippet

Sponsor: Hospices Civils de Lyon | Conditions: Sleep Disorders | Phase 2 | Status: COMPLETED